If You Invested $10,000 in Veeva in 2013, This Is How Much You Would Have Today
Veeva Systems (NYSE: VEEV) started trading on the New York Stock Exchange in October 2013 at $20 per share. If you could get your hands on the stock at that price on its opening day, a $10,000 investment would've yielded 500 newly minted Veeva shares. Those shares have compounded at 29.8% per year and at the time of this writing are worth about $209 each, or $104,500. That's more than 10 times your money in just shy of nine years.
What's more impressive, the stock has come down more than 35% over the last year from about $330 per share. A year ago, original investors would have earned 42% compounded annually, or 16 times their cost. Even after its mighty fall this year, the stock has yielded breathtaking returns. It has been a model for buy-and-hold investors, but we're always looking forward in the stock world. Can Veeva stock produce another prodigious run?
Pharmaceutical and biotech companies face an extraordinary amount of regulation. Laws governing drug development and marketing come down from every country and state, and those regulations evolve constantly. The cumbersome process of complying with regulatory burdens can slow the time to market for drugmakers dramatically, especially for multinational corporations. That's where Veeva comes in.
Source Fool.com
